Skip to content

Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation

Development of Avatar-based Intervention to Support Patients Undergoing Reduced-Intensity Allogenic Stem Cell Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05600101
Enrollment
18
Registered
2022-10-31
Start date
2022-12-06
Completion date
2023-05-16
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic Cell Transplantation

Keywords

Reduced intensity conditioning allogeneic transplant, Stem cell transplantation, Avatar-based technology, Artificial intelligence

Brief summary

The goal of this research study is to provide an avatar-based technology during a subject's stay for participants who have been admitted to the hospital for reduced-intensity conditioning (RIC) allogeneic transplant. The intervention received will be the care.coach technology.

Detailed description

This research study is a Pilot Study, which means the investigators are studying the application in a smaller group of people to understand whether the technology, care.coach, is easy to use. This is a single site study at Dana-Farber Brigham and Women's Cancer Center. * Aim 1 of the study will be an 8 - 10 participant focus group of nurses, navigator nurses, physicians, and NPs/PAs to refine the avatar protocols. * Aim 2 of the study will be a pilot of 18 participants undergoing RIC allogeneic HCT in the hospital. * The research study procedures include screening for eligibility, a brief call with a research assistant during use of care.coach avatar, and a survey after study completion. * The avatar is designed to communicate with participants regarding transplantation education and provide reminders for eating, drinking, and activity. * care.coach is a digital, avatar-based technology that communicates using natural speech software. * care.coach is supporting this research by providing Dana-Farber access to its technology. The National Cancer Institute (NCI) also supports this research.

Interventions

BEHAVIORALCare.Coach

Care.coach is a human-in the-loop conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for HCT focus group: * Age 18+. * DFCI/HCC HCT nurse navigators, inpatient HCT nurses, and HCT physicians and extenders (NP/PA). Inclusion Criteria for care.coach pilot: * Age 18+. * Admitted for reduced-intensity conditioning (RIC) allogeneic HCT

Exclusion criteria

for care.coach pilot: Deemed by clinical staff or RA to be unable to converse with an avatar, due to: * Severe, uncorrectable hearing impairment and simultaneous severe, uncorrectable vision impairment. * Severe speech impairment that precludes understanding by staff (and by extension, by the avatar). * Not fluent in English.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants RetainedBaseline to 3 weeksParticipants complete study protocol, including post-completion survey, from enrollment to hospital discharge or 3 weeks from enrollment (whichever is earlier).

Secondary

MeasureTime frameDescription
Final Cohort Dissatisfaction Rate3 weeksPercent of patients dissatisfied with the avatar in the third 6-patient cohort.
The Completion Rate Post-Pilot Survey3 weeksRate of completion of post-pilot survey within 1 week of discharge

Countries

United States

Participant flow

Recruitment details

Recruitment was conducted by a trained research assistant (RA) utilizing HIPAA-compliant and DFCI IRB approved patient approach procedures. A total of 18 participants were consented. Patients were approached and consented upon inpatient admission for RIC HCT. Patients were consented beginning on 12/6/2022 through 5/3/2023.

Pre-assignment details

There were no significant events in the study for any patients between their enrollment and assignment to an arm or group of the study.

Participants by arm

ArmCount
Care.Coach Pilot
The research study procedures include screening for eligibility, a brief call with a research assistant after tablet is given to subject, and a survey after a subject has completed the study. * 3 consecutive cohorts of 6 RIC HCT patients each. * care.coach is a human-in the-loop conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates. A subject uses the avatar for up to 3 weeks. Care.Coach: Care.coach is a human-in the-loop conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates.
18
AI HCT Focus Group
A structured focus group arm consisted of HCT nurse navigators, inpatient HCT nurses, and HCT physicians. Participants provided their perspectives on patient facing artificial intelligence technology which was used to inform care.coach software protocols. Participation was limited to a single 60 minute focus group.
10
Total28

Baseline characteristics

CharacteristicCare.Coach PilotTotalAI HCT Focus Group
Age, Categorical
<=18 years
0 Participants0 Participants
Age, Categorical
>=65 years
7 Participants7 Participants
Age, Categorical
Between 18 and 65 years
11 Participants11 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants2 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants2 Participants
Race (NIH/OMB)
White
13 Participants13 Participants
Region of Enrollment
United States
18 Participants28 Participants10 Participants
Sex: Female, Male
Female
11 Participants11 Participants
Sex: Female, Male
Male
7 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 180 / 0
other
Total, other adverse events
0 / 180 / 0
serious
Total, serious adverse events
0 / 180 / 0

Outcome results

Primary

Number of Participants Retained

Participants complete study protocol, including post-completion survey, from enrollment to hospital discharge or 3 weeks from enrollment (whichever is earlier).

Time frame: Baseline to 3 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Care.Coach PilotNumber of Participants Retained18 Participants
Secondary

Final Cohort Dissatisfaction Rate

Percent of patients dissatisfied with the avatar in the third 6-patient cohort.

Time frame: 3 weeks

ArmMeasureValue (NUMBER)
Care.Coach PilotFinal Cohort Dissatisfaction Rate0 percentage of particpants
Secondary

The Completion Rate Post-Pilot Survey

Rate of completion of post-pilot survey within 1 week of discharge

Time frame: 3 weeks

ArmMeasureValue (NUMBER)
Care.Coach PilotThe Completion Rate Post-Pilot Survey72 Survey Completion Rate Percentage

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026